Ellen Mourão Soares Lopes

Ellen Mourão Soares Lopes

Auto-generated profile, based on publicly available information

Ellen Mourão Soares Lopes

Division of Neurogenetics and Neuromuscular Disorders Hospital Infantil Albert Sabin Fortaleza Ceará Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2026 in Journal of the Peripheral Nervous System
Verified
Journal Article
Open access
GGGustavo Rodrigues Ferreira Gomes
Gustavo Rodrigues Ferreira Gomes
ACAntonio Edvan Camelo-Filho
Antonio Edvan Camelo-Filho
ELEllen Mourão Soares Lopes
Ellen Mourão Soares Lopes
RARaquel Diógenes Alencar
Raquel Diógenes Alencar
ERErlane marques Ribeiro
Erlane marques Ribeiro
APAndré Luiz Santos Pessoa
André Luiz Santos Pessoa
Background and Aims: Maple syrup urine disease (MSUD) is an inherited disorder of branched‐chain amino acid metabolism caused by deficiency of the branched‐chain α‐keto acid dehydrogenase complex. Neurological manifestations predominantly involve the central nervous system, whereas peripheral nervous system involvement has been rarely reported. Results: We report a genetically confirmed case of intermittent MSUD caused by compound heterozygous pathogenic variants in DBT in a female patient who developed recurrent ataxic episodes beginning in early childhood, followed by acute ascending weakness during metabolic decompensation at 12 years of age. Initially suspected to have Guillain–Barré syndrome, subsequent biochemical and molecular investigations established the diagnosis of MSUD. Five years later, despite good metabolic control and substantial functional recovery, follow‐up nerve conduction studies, and electromyography demonstrated a chronic demyelinating sensorimotor polyneuropathy. Clinical examination additionally revealed bilateral pes cavus and persistent mild distal lower‐limb weakness. Interpretation: Only a few cases of peripheral neuropathy associated with MSUD have previously been described. Our findings expand the phenotypic spectrum by documenting the longitudinal evolution from recurrent childhood neurological episodes to chronic mixed demyelinating–axonal polyneuropathy. The clinical course supports the hypothesis that repeated metabolic decompensation may contribute to cumulative peripheral nerve injury. Although the precise mechanisms remain uncertain, mitochondrial dysfunction, impaired energy metabolism, oxidative stress, and branched‐chain amino acid and α‐keto acid toxicity provide plausible explanations. Conclusion: Peripheral neuropathy should be recognized as a potential manifestation of MSUD, including intermittent phenotypes. Long‐term neurological follow‐up incorporating electrophysiological evaluation may improve recognition of peripheral nervous system involvement and contribute to a more complete characterization of the disease.